Furthermore, a CRISPR/Cas9 system was used to knock out TET1 to promote tumor growth, which showed that TET1 expression is closely associated with tumor growth, thus chrysin is expected to become an effective target for this emerging gastric cancer (162). Here, TET1 is linked to gastric cancer.